Though left unfinished, this is the finest carved tomb in the Valley of the Nobles. Ramose was a governor of Thebes and vizier of Egypt under both Amenophis III and Amenophis IV (better known as ...
Adding the VEGF inhibitor ramucirumab (Cyramza) to the EGFR inhibitor osimertinib (Tagrisso) slowed progression of untreated EGFR-positive non-small cell lung cancer (NSCLC) by 9 months compared with ...
Enter the embalmer's workshop, where you are to prepare the body of Ramose, officer to the king, for burial.The chief embalmer, Kha, will be watching your work closely. Complete your task ...
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR-Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial) ...
Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials ...
"Data from the phase II, randomized, multicenter RAMOSE trial indicate that the addition of ramucirumab to osimertinib significantly prolongs PFS in TKI [tyrosine kinase inhibitor]-naive patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback